The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

13.10

-1.50

(-10.27%)

At close: 04:00PM EDT

13.10

0.00

(0.00%)

After hours:

04:06PM EDT

Currency in USD

Earnings estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	7	7	8	8
Avg. Estimate	-1.23	-1.03	-6.99	-4.96
Low estimate	-1.65	-1.67	-20	-6.69
High estimate	-0.91	-0.6	-4.35	-3.35
Year ago EPS	-1.86	-1.33	-6.38	-6.99

Revenue estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	7	7	6	7
Avg. Estimate	16.88M	17.36M	67.82M	74.92M
Low estimate	14M	13M	59M	50M
High estimate	20M	21M	72.6M	111.94M
Year ago sales	N/A	18.93M	79.2M	67.82M
Sales growth (year/est)	N/A	-8.30%	-14.40%	10.50%

Earnings history	29/06/2023	29/09/2023	30/12/2023	30/03/2024
Est. EPS	-2.34	-2.15	-1.19	-1.33
Actual EPS	-1.86	-1.33	-1.58	-1.47
Difference	0.48	0.82	-0.39	-0.14
Surprise %	20.50%	38.10%	-32.80%	-10.50%

EPS trend	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Current estimate	-1.23	-1.03	-6.99	-4.96
7 days ago	-1.23	-1.03	-5.09	-4.67
30 days ago	-1.23	-1.03	-5.09	-4.67
60 days ago	-1.23	-1.03	-5.09	-4.67
90 days ago	-1.16	-1.01	-4.83	-4.63

EPS revisions	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	1	1

Growth estimates	ENTA	Industry	Sector(s)	S&P 500
Current qtr.	33.90%	N/A	N/A	N/A
Next qtr.	22.60%	N/A	N/A	N/A
Current year	-9.60%	N/A	N/A	N/A
Next year	29.00%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	-10.60%	N/A	N/A	N/A